SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950144-04-005537
Filing Date
2004-05-14
Accepted
2004-05-14 17:22:36
Documents
5
Period of Report
2004-03-31

Document Format Files

Seq Description Document Type Size
1 ADVANCED VIRAL RESEARCH FORM 10-Q g89207e10vq.htm 10-Q 352905
2 CERTIFICATION OF CEO PURSUANT TO SECTION 302 g89207exv31w1.htm EX-31.1 7468
3 CERTIFICATION OF CFO PURSUANT TO SECTION 302 g89207exv31w2.htm EX-31.2 7160
4 CERTIFICATION OF CEO PURSUANT TO SECTION 906 g89207exv32w1.htm EX-32.1 2328
5 CERTIFICATION OF CFO PURSUANT TO SECTION 906 g89207exv32w2.htm EX-32.2 2302
  Complete submission text file 0000950144-04-005537.txt   374305
Mailing Address 200 CORPORATE BOULEVARD SOUTH . YONKERS NY 10107
Business Address 200 CORPORATE BOULEVARD SOUTH . YONKERS NY 10107 9143767383
ADVANCED VIRAL RESEARCH CORP (Filer) CIK: 0000786623 (see all company filings)

IRS No.: 592646820 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 033-02262-A | Film No.: 04808981
SIC: 2834 Pharmaceutical Preparations